Compare WIX & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WIX | OMCL |
|---|---|---|
| Founded | 2006 | 1992 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Computer Manufacturing |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2013 | 2000 |
| Metric | WIX | OMCL |
|---|---|---|
| Price | $51.80 | $40.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 6 |
| Target Price | ★ $134.67 | $55.83 |
| AVG Volume (30 Days) | ★ 1.2M | 691.4K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | $15.80 | $6.77 |
| Revenue Next Year | $13.21 | $5.22 |
| P/E Ratio | ★ $28.86 | $159.44 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $40.00 | $28.09 |
| 52 Week High | $190.92 | $51.84 |
| Indicator | WIX | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 51.44 | 41.36 |
| Support Level | $45.62 | $35.81 |
| Resistance Level | $54.55 | $45.72 |
| Average True Range (ATR) | 2.68 | 1.84 |
| MACD | 0.25 | -0.68 |
| Stochastic Oscillator | 59.91 | 16.68 |
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years, it has invested heavily and introduced its Wix Studio offering for partners, which are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.